Articles tagged with "Glucocorticoids"

Fellow’s Forum Case Report: Takayasu’s Arteritis

Ashwini Komarla, MD; Michael George, MD; Antoine Sreih, MD; & Chris Derk, MD, MS | May 1, 2014

How this rare form of large-vessel vasculitis affects different portions, branches of aorta and ways to diagnose, treat and manage the disease

2013 ACR/ARHP Annual Meeting: Researchers Explore Role of Pathogens, Quality of Care in Rheumatoid Arthritis

Mary Beth Nierengarten | January 1, 2014

Funding by the Rheumatology Research Foundation has furthered studies on the impact of infectious agents and autoantigens, periodontal disease, and disease-modifying antirheumatic drugs on patients with RA

Prednisone Might be the Missing Ingredient in the American College of Rheumatology’s Recommendations for Treating Patients with Rheumatoid Arthritis

John Kirwan, MD | April 1, 2013

A combination therapy with glucocorticoids may be the gold standard for treating patients with rheumatoid arthritis (RA)

Is Predisone 3 mg/day an Appropriate Dose for Patients with Rheumatoid Arthritis?

Theodore Pincus, MD | April 1, 2013

Long-term, low-dose prednisone at less than 5 mg/day appears tolerable and effective for many patients with rheumatoid arthritis (RA)

Maintenance of Remission in ANCA-Associated Vasculitis

Paul A. Monach, MD, PhD | September 5, 2012

Relapses are common, but difficult to predict and prevent.

ACR Issues Guidelines, Recommendations for Lupus Nephritis, RA

Kathy Holliman | June 10, 2012

Detailed screening and treatment recommendations based on current evidence, extensive literature review.

Case Study: 66-Year-Old Man with Visual Loss, Headache, Hematuria, Chronic Sinusitis

Eli Miloslavsky, MD | May 8, 2012

A 66-year-old man presented to the hospital with left-sided visual loss, headache, hematuria, and symptoms of a chronic sinusitis.

Treatment Patterns and Trends for Spondylarthropathies

Vanessa Caceres | April 6, 2012

Methotrexate is a commonly used disease-modifying antirheumatic drug (DMARD) for treating patients with psoriatic arthritis (PsA). However, is it truly as effective as many think it is? That’s the question raised during the session “Spondylarthropathies: Recent Insights,” which took place at the 2011 ACR/ARHP Annual Scientific Meeting in November.

Quality Measurement Improves Rheumatology Outcomes

Kathleen Louden | January 13, 2012

Innovations in health information technology can have significant impact

Making of the Guidelines

Vanessa Caceres | March 18, 2011

Panel considered new drugs and tools in the 2010 update